Viloxazine Hydrochloride

盐酸维洛沙秦

Report date: 2024/06/04 16:19:13
NME

Base Information

Drug NameViloxazine Hydrochloride
Drug Alias Name维洛沙秦viloxazineviloxazinumviloxazinaVicilan +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepression
Global Approved IndicationsAttention Deficit Disorder with Hyperactivity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/04/02
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSupernus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Enhua Biomedical Technology Co LtdKnight Therapeutics IncSupernus Pharmaceuticals Inc +[4] 
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityDepression
Inactive IndicationsN/A

Other Information

ATC CodeN06AX09
Related LinksWikipediaDrugBankKEGG